
|Articles|November 15, 2003
FDA to allow inserts for keratoconus patients
Des Plaines, IL-Micro-thin prescription inserts (Intacs, Addition Technology Inc.) may be used to reduce or eliminate myopia and astigmatism in patients with keratoconus for whom restoration of functional vision is no longer possible with contact lenses or glasses, under a new designation by the FDA.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Study identifies 6 key genes linking air pollution to dry eye disease
2
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
3
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
4
Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism
5


















































.png)


